INFLECTION MEDICINE Trademark

Trademark Overview

On Friday, July 19, 2024, a trademark application was filed for INFLECTION MEDICINE with the United States Patent and Trademark Office. The USPTO has given the INFLECTION MEDICINE trademark a serial number of 98656512. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, July 19, 2024. This trademark is owned by Inflection Medicine, Inc.. The INFLECTION MEDICINE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

diagnostic tests for detecting genetic diseases and disorders

medical diagnostic and treatment services, namely, whole genome sequencing testing for treating of genetic disease and disorders; clinical whole genome sequencing testing to enable the prevention, diagnosis and treatment of genetic diseases and disorders; providing medical screening for detecting genetic diseases in newborns; medical diagnosis, namely, translations of complex genomic sequencing for use in individualized patient treatment plans by healthcare providers for the diagnosis and treatment of genetically-linked diseases and conditions; providing genetic counseling and information services

development and commercialization of diagnostics for genetic diseases and disorders; development and commercialization of technology to improve clinical outcomes of individuals with genetic diseases and disorders; development and commercialization of diagnostics for identifying genetic diseases and disorders; genome sequencing services; clinical rapid whole genome sequencing test to enable the prevention, diagnosis and treatment of genetic diseases and disorders; development and commercialization of technology that provides clinical guidance; software platform for data analysis, data management, data storage, data interpretation, and report generation, all in the field of genetics and genetic testing; clinical decision support technology to assist in the translation of complex genomic sequencing for use in treatment plans by healthcare providers
inflection medicine

General Information

Serial Number98656512
Word MarkINFLECTION MEDICINE
Filing DateFriday, July 19, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, July 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the words INFLECTION and MEDICINE. Between the words INFLECTION and MEDICINE is the design of a square within which is a curved line running through the center of the right and left portions of the square.
Goods and Servicesdiagnostic tests for detecting genetic diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicesmedical diagnostic and treatment services, namely, whole genome sequencing testing for treating of genetic disease and disorders; clinical whole genome sequencing testing to enable the prevention, diagnosis and treatment of genetic diseases and disorders; providing medical screening for detecting genetic diseases in newborns; medical diagnosis, namely, translations of complex genomic sequencing for use in individualized patient treatment plans by healthcare providers for the diagnosis and treatment of genetically-linked diseases and conditions; providing genetic counseling and information services
Goods and Servicesdevelopment and commercialization of diagnostics for genetic diseases and disorders; development and commercialization of technology to improve clinical outcomes of individuals with genetic diseases and disorders; development and commercialization of diagnostics for identifying genetic diseases and disorders; genome sequencing services; clinical rapid whole genome sequencing test to enable the prevention, diagnosis and treatment of genetic diseases and disorders; development and commercialization of technology that provides clinical guidance; software platform for data analysis, data management, data storage, data interpretation, and report generation, all in the field of genetics and genetic testing; clinical decision support technology to assist in the translation of complex genomic sequencing for use in treatment plans by healthcare providers

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 19, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 19, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInflection Medicine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02215

Trademark Events

Event DateEvent Description
Friday, July 19, 2024NEW APPLICATION ENTERED

Related Keywords

medicine inflection genetic diseases disorders treatment sequencing clinical data commercialization development genome